Directed evolution of a stem-helix–targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity
PLOS Pathogens · 2026
DOI: 10.1371/journal.ppat.1014393 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Panpan Zhou und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America. Hauptthemen laut MEDLINE: Antibodies, Viral, Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus, Middle East Respiratory Syndrome Coronavirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, Bill & Melinda Gates Foundation.
Abstract (Originalsprache)
Broadly neutralizing antibodies (bnAbs) targeting conserved regions of the betacoronavirus spike are important for pan-betacoronavirus protection and pandemic preparedness. Here, we report the isolation of a human monoclonal antibody, CC65.1, from a SARS-CoV-2 convalescent donor that targets the conserved S2 stem helix region. CC65.1 neutralizes various sarbecoviruses, including SARS-CoV-2, and binds to the MERS-CoV spike but lacks MERS-CoV-neutralizing activity due to insufficient binding affinity. We utilized directed evolution to enhance the binding affinity of CC65.1 for the MERS-CoV S2 stem helix, yielding engineered antibody variants with newly acquired MERS-CoV-neutralizing activity. High-resolution structural analysis reveals key paratope mutations that enhance binding and stabilize epitope engagement. Our findings demonstrate the potential of in vitro affinity maturation to expand the neutralization breadth of stem-helix-targeting antibodies across divergent betacoronaviruses. This work supports the development of engineered bnAbs for broadly protective betacoronavirus countermeasures and provides a strategy for achieving cross-lineage neutralization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
- Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.
- Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.
ORCID-Profile: Raiees Andrabi
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- Bill & Melinda Gates Foundation
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Bill and Melinda Gates Foundation
Zitieren
APA
Zhou, P., Yuan, M., Zhang, Y., Limbo, O., Song, G., Zhao, F., Liu, H., He, W. T., Capozzola, T., Callaghan, S., Avillion, G., Li, X., Beutler, N., Yong, P., Anzanello, F., Rogers, T. F., Burton, D. R., Jardine, J. G., Wilson, I. A., & Andrabi, R. (2026). Directed evolution of a stem-helix–targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014393
Vancouver
Zhou P, Yuan M, Zhang Y, Limbo O, Song G, Zhao F, et al. Directed evolution of a stem-helix–targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014393
BibTeX
@article{Zhou2026,
author = {Zhou, Panpan and Yuan, Meng and Zhang, Yuexiu and Limbo, Oliver and Song, Ge and Zhao, Fangzhu and Liu, Hejun and He, Wan-Ting and Capozzola, Tazio and Callaghan, Sean and Avillion, Gabriel and Li, Xuduo and Beutler, Nathan and Yong, Peter and Anzanello, Fabio and Rogers, Thomas F and Burton, Dennis R and Jardine, Joseph G and Wilson, Ian A and Andrabi, Raiees},
title = {Directed evolution of a stem-helix–targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity},
journal = {PLOS Pathogens},
year = {2026},
doi = {10.1371/journal.ppat.1014393}
}
EUVIMED